J A Gallagher Selected Research

Calcium

2/2010	Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.
12/2000	Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J A Gallagher Research Topics

Disease

25	Alkaptonuria 03/2024 - 11/2008
4	Bone Resorption 01/2007 - 03/2001
2	Body Weight (Weight, Body) 06/2022 - 11/2019
2	Osteoporotic Fractures 12/2021 - 04/2000
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2018 - 12/2011
2	Ochronosis 10/2018 - 01/2018
2	Disease Progression 01/2018 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 01/2015
1	Weight Gain 06/2022
1	Osteoporosis 12/2021
1	Tyrosinemias (Tyrosinemia) 09/2019
1	Alkaptonuric ochronosis 01/2018
1	Rare Diseases (Rare Disease) 01/2014
1	Calculi (Calculus) 02/2010
1	Wounds and Injuries (Trauma) 09/2002
1	Osteosarcoma (Osteogenic Sarcoma) 05/2001
1	Breast Neoplasms (Breast Cancer) 12/2000
1	Fibrous Dysplasia of Bone 11/2000
1	Pain (Aches) 11/2000
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 11/2000
1	Metaplasia 09/2000
1	Measles 09/2000
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 09/2000
1	Osteoarthritis 04/2000

Drug/Important Bio-Agent (IBA)

16	nitisinone (Orfadin)FDA Link 06/2022 - 01/2014
13	Tyrosine (L-Tyrosine)FDA Link 06/2022 - 12/2011
9	Homogentisic AcidIBA 03/2024 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2001
3	EnzymesIBA 03/2016 - 02/2010
3	NucleotidesIBA 06/2004 - 12/2000
2	Urea (Carbamide)FDA LinkGeneric 06/2022 - 11/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 05/2019 - 01/2019
2	PolymersIBA 10/2018 - 02/2010
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2015
2	Homogentisate 1,2-Dioxygenase (Homogentisate 1,2 Dioxygenase)IBA 03/2016 - 02/2010
2	CalciumIBA 02/2010 - 12/2000
2	Purinergic P2X7 ReceptorsIBA 10/2003 - 05/2001
2	Adenosine Triphosphate (ATP)IBA 09/2002 - 12/2000
2	Parathyroid Hormone-Related ProteinIBA 11/2000 - 09/2000
1	CreatinineIBA 06/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 06/2022
1	Diphosphonates (Bisphosphonates)IBA 12/2021
1	Teriparatide (Parathar)FDA Link 12/2021
1	AcidsIBA 09/2019
1	4-hydroxyphenyllactic acidIBA 09/2019
1	5-hydroxyindoleIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018
1	ImmunosorbentsIBA 01/2015
1	catch-relaxing peptide (Mytilus)IBA 01/2015
1	SaltsIBA 02/2010
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2007
1	Protein Isoforms (Isoforms)IBA 01/2007
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2002
1	Messenger RNA (mRNA)IBA 05/2001
1	Parathyroid Hormone (Parathormone)IBA 03/2001
1	Uridine Triphosphate (UTP)IBA 12/2000
1	adenosine 5'-O-(3-thiotriphosphate)IBA 12/2000
1	Purinergic Receptors (Receptors, Purine)IBA 12/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2000
1	hydroxide ionIBA 11/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2000
1	parathyroid hormone-related protein (1-34)IBA 09/2000
1	RNA (Ribonucleic Acid)IBA 09/2000
1	CytokinesIBA 04/2000

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2014
1	Protein-Restricted Diet (Diet, Protein Restricted) 06/2022
1	Slit Lamp 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2000